Pharmacology Books
Taylor & Francis Inc Sensitive Skin Syndrome
Book SynopsisSensitive skin is a widely reported condition where affected individuals experience enhanced and unpleasant sensations of itching, burning and discomfort upon exposure to a wide range of environmental factors. Considerable progress in recent years has shed light on multiple aspects of this condition. This new edition sums up the advances in pathophysiology, methods of investigation, effects of environmental factors and clinical considerations in evaluation and management of affected individuals. This book provides a blend of basic science and methodologies for interested investigators as well as practical points in clinical management of patients. Table of ContentsSection I Introduction and Background 1 What is sensitive skin? Renée J.H. Richters, Natallia E. Uzunbajakava, Piet E.J. van Erp, and Peter C.M. van de Kerkhof2 Sensitive skin: a review of prevalence worldwide Charles Taieb and Laurent Misery3 Skin structure and function Golara Honari 4 The somatosensory system Francis McGlone and David ReillySection II Pathophysiology of Sensitive Skin 5 Stratum corneum and sensitive skin Enzo Berardesca6 Altered somatosensory pathways Eun Ju Kim, Dong Hun Lee, and Jin Ho Chung7 Itch and sensitive skin Martin SchmelzSection III Investigative Methods 8 Challenges of investigationLidia Maroñas-Jiménez, Elena González-Guerra, and Aurora Guerra-Tapia 9 Self-assessment of sensitive skinCharles Taieb and Laurent Misery10 Confocal Raman Micro-Spectroscopy: a new paradigm in the diagnosis of sensitive skin?Denise Falcone, Natallia E. Uzunbajakava, Piet E.J. van Erp, and Peter C.M. van de Kerkhof11 Regarding the quantification of the human skin barrier in Sensitive Skin SyndromeLuís Monteiro Rodrigues, Henrique Silva, and Catarina Rosado12 Irritant reactivity tests David A. Basketter13 Neurosensory assessment Roland JourdainSection IV Clinical Considerations 14 Sensitive skin: there is a link with ethnicity?Laurent Misery and Charles Taieb15 Gender and age influence on sensitive skinRosa Marie Andersen16 Sensitive skin: do we observe an impact on quality of life?Laurent Misery and Charles Taieb17 Perceived sensitive skin at different anatomic sites Miranda A. Farage18 Sensitive skin and non-eczematous dermatoses Ian McDonald, Helen Rea, and Martin Steinhoff19 Sensitive skin and eczematous dermatoses Arun C Inamadar and Aparna PalitSection V Environmental Factors and Everyday Products 20 Influence of air pollution on skin Sparsha Saxena and Golara Honari21 Sensitive skin, skin care products and cosmeticsEnzo Berardesca22 Fabrics and sensitive skin Gerald E. Pierard and Howard I. MaibachSection VI Management 23 Dermatotoxicology and sensitive skin syndrome Golara Honari and Howard I. Maibach 24 Formulations for sensitive skin Golara Honari and Howard I. Maibach25 Treatments for sensitive skin Martina Kerscher and Heike BuntrockIndex
£170.00
Taylor & Francis Inc Drugs That Changed the World
Book SynopsisDrugs are used in the diagnosis, alleviation, treatment, prevention or cure of disease. This is a book about drugs, how they came to be, and how they exert their magic'. Today we have drugs to protect against infectious diseases, to alleviate aches and pains, to allow new organs to replace the old, and for brain functions to be modified. Yet, for the most part the manner by which drugs are developed and by whom remains a mystery. Drugs are more than just a pill or liquid and some have markedly altered history. The author has selected a few drugs highlights representing milestones affecting our well-being and influencers of social change. The stories told are dramatic and include spectacular successes and dismal failures. And the people about whom these stories are told are both saints and sinners selfless and conniving bold and mercurial and shy and retiring loner. The drugs themselves mirror the diversity of their origin stories and the author assembles all sides of these fascinTable of ContentsMalaria and Antimalarials. The Painkiller, Aspirin. Ether, Chloroform, Cocaine, Morphine, Heroin and Anesthesia. The Pill. Diabetes and Insulin. Smallpox and Vaccination. Vaccines to Combat Infectious Diseases. The Great Pox Syphilis and Salvarsan. Prontosil, Pyrimethamine, and Penicillin. AIDS, HIV and Antiretrovirals. Organ Transplantation and Cyclosporine. Malaria, Madness and Chlorpromazine.
£69.99
American Society for Microbiology Antibiotics: Challenges, Mechanisms,
Book Synopsis
£93.56
Taylor & Francis Inc Calpains: Pharmacology and Toxicology of a
Book SynopsisThis new edition offers a clear and through examination of the most recent results of thirty years of research on calcium-activated-neutral protease (CANP or Calpain). Coverage includes the implications of the recently gained ability to produce functionally active recombinant calpain in various human disorders such as cerebal ischemia, traumatic brain and spinal cord injury, cataract formation, myocardial infarction, and Alzheimer's disease. The resulting research to find more selective calpain inhibitors is also discussed. With a copy of Calpain: Pharmacology and Toxicology of Calcium Dependent Protease you will better understand why the calpain research area is such an exciting and promising one.Table of Contents1. The Calpain Super Family Yasuko Ono, Hiroyuki Sorimachi and Koichi Suzuki 2. Structure of Calpastian and its Inhibitory Control of Calpain Emiko Takano and Masatoshi Maki 3. The Expression of Calpain in Bacteria and in Insect Cells John Elce 4. Structure and Assembly of the Calcium-Binding Domains of Calpain Sthanam Narayana, John Elce, Debashish Chattopadhyay, Guang-da Lin, Mike Carson, Helen Blanchard, Pawel Grochulski and Miroslaw Cygler 5. Calpain Substrates, Assay Methods, Regulation, and its Inhibitory Agents Kevin Wang and Po-wai Yuen 6. Calpain In Signal Transduction John Fox and Takaomi Saido 7. The Calpain System in Muscle Tissue Ahmed Ouali and Rong-Ghi Chou 8. Involvement of Calpains in Cell Cycle G-1 - to S-Phase Progression Ronald Mellgren, Wenli Zhang, Qin Lu and Richard Lane 9. Calpain in Excitotoxicity, Cerebral Ischemia and Neuronal Apoptosis Kevin Wang, Po-wai Yuen and Kevin Lee 10. The Contribution of Calpain Proteolysis to Neuronal Death Following Traumatic Brain Injury Ronald Hayes, Andreas Kampfl and Rand Posmantur 11. The Pathophysiological Role of Calpain in Spinal Cord Injury Naren Banik, Donald Shields, Swapan Ray and Edward Hogan 12. Calpain-Mediated Proteolysis of Neuronal Structural Proteins Rodney Guttmann and Gail Johnson 13. Calpain and Cerebrovascular Injury Sung-Don Kang, Adam Arthur, Elisa Beres, Andrea Fergus, Chris Boals, Murad Bavbek and Kevin Lee 14. Calpains in the Pathogenesis of Alzheimer's Disease Ralph Nixon and Panaiyur Mohan 15. Calpain and Apoptosis in the Immune System Margaret Squier and J. John Cohen 16. The Role of Calpain in Renal Proximal Tubular and Hepatocyte Injury Charles Edelstein and Robert Schrier 17. Calpains in the Lens of the Eye Thomas Shearer, Hong Ma, M.Shih, Chiho Fukiage and Mitsoyoshi Azuma 18. Calpain Activation and Expression in Toxicant Injury Susan Starcevic and Raymond Novak 19. Calpain 3 (p94) in Limb Girdle Muscular Dystrophy Type 2A Isabelle Richard, Jacques Beckmann and Michael Fardeau 20. Genetic Analysis of Calpain Isoform Function in Skeletal Muscle: New Stratagies to Study Protease Function Bor-rung Ou, Jing Huang, Neil Forsberg, Mohammad Ilian and Dong-hyun Hong 21. Crustacean Calcium-Dependent Proteinases Jill Beyette and Donald Mykles 22. Calpains in Drosophila and Mammals: Structure and Implications in Neuronal Function Peter Friedrich, Peter Tompa and Gaspar Jekely. Azuma, Senju Pharmaceutical Co., Japan, Naren Banik, Medical University of South Carolina, USA, Murad Bavbek, University of Virginia, USA, Jacques Beckmann, CNRS URA 1922, France, Elisa Beres, University of Virginia, USA, Jill Beyette, University of Cincinnati, USA, Helen Blanchard, National Research Council, Canada, Chris Boals, University of Virginia, USA, Mike Carson, University of Alabama, USA, Debasish Chattapadhyay, University of Alabama, USA, Rong-Ghi Chou, National Chia-Yi Institute of Agriculture, China, J. John Cohen, University of Colordo Health Sciences Centre, USA, Miroslaw Cygler, National Research Council, Canada, Charles Edelstein, University of Colorado, USA, John Elce, Queens University, Canada, Michel Fardeau, Hospital Salpetiere, Andrea Fergus, University of Virginia, USA, Neil Forsberg, Oregon State University, USA, Joan Fox, Cleveland Clinic Foundation, USA, Peter Friedrich, Hungarian Academy of Sciences, Chiho Fukiage, Senju Pharmaceutical Co., Japan, Darrell Goll, University of Arizona, USA, Pawel Grochulski, National Research Council, Canada, Rodney Guttmann, University of Alabama, USA, Ronald Hayes, University of Texas - Houstan Health Centre, USA, Edward Hogan, Medical University of South Carolina, USA, Dong-hyun Hong, University of Toronto, Canada, Jing Huang, Oregon State University, USA, Mohammad Ilian, Lincoln University, Gaspar Jekely, Hungarian Academy of Sciences, Gail Johnson, University of Alabama, USA, Andreas Kamfl, University of Insbruck, Austria, Sung-Don Kang, University of Virginia, USA, Richard Lane, Medical College of Ohio, USA, Kevin Lee, University of Virginia, USA, Guang-da Lin, University of Alabama, USA, Qin Lu, Medical College of Ohio, USA, Hong Ma, Oregon State University, USA, Masatoshi Maki, Nagoya University, Japan, Ronald Mellgren, Medical College of Ohio, USA, Panaiyur Mohan, New York University Medical Centre, USA, Donald Mykles, Colorado State University, USA, Sthanam Narayana, University of Alabama, USA, Ralph Nixon, New York University Medical Centre, USA, Raymond Novak, Wayne State University, USA, Yasuko Ono, University of Tokyo, Japan, Ahmed Ouali, Station de Recherches sur la Viade, France, Bor-rung Ou, Tunghai University, China, Rand M. Posmantur, Bristol-Myers Squibb Company, USA, Swapan Ray, Medical University of South Carolina, USA, Isabelle Richard, CNRS URA 1922, France, Takaomi Saido, RIKEN Brain Science Institute, Japan, Robert Schrier, University of Colorado, USA, Thomas Shearer, Oregon Health Sciences University, USA, Donald Shields, Medical University of South Carolina, M. Shih, Oregon Health Sciences University, USA, Hiroyuki Sorimachi, University of Tokyo, Japan, Margaret Squier, University of Colorado Health Sciences Centre, USA, Susan Starcevic, Wayne State University, USA, Koichi Suzuki, University of Tokyo, Japan, Emiko Takanao, Kyoto National Hospital, Japan, Richard Taylor, Institut National de la Recherche Agronomique, France, Valery Thompson, University of Arizona, USA, Peter Tompa, Hungarian Academy of Sciences, Kevin Wang, Warner Lambert Company, USA, Po-wai Yuen, Warner Lambert Company, USA, Wenli Zhang, Cornell University Medical College.
£240.00
John Wiley and Sons Ltd Pharmaceutical Science to Improve the Human
Book SynopsisThis Annals volume includes scholarly summaries of scientific achievement by winners and finalists candidates of the 2011 Prix Galien USA awards for achievement in pharmaceutical science. Contributions by GlaxoSmithKline, Amgen, Pfizer, and Janssen Biotech present advances in biotechnology and pharmaceutical agents that combat a range of diseases. NOTE: Annals volume are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit: http://ordering.onlinelibrary.wiley.com/subs.asp?ref=1749-6632&doi=10.111/(ISSN)1749-6632 ACADEMY MEMBERS: Please contact the New york Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Sciences receive full-text access to Annals online and discounts on print volumes. Please visit http://www.nyas.org/MemberCenter/Join.aspx for more information about becoming a member.
£99.00
Taylor & Francis Inc Functional Informatics in Drug Discovery
Book SynopsisIntegrating various technologies with informational systems provides vast improvements to the overall research and development that occur in the biopharmaceutical industry. One of the first books to explore this area, Functional Informatics in Drug Discovery examines all aspects of technology integration and information flow in a biopharmaceutical enterprise and outlines the specific technologies used at various stages of drug development. With contributions from leaders in academia, information technology, and the pharmaceutical industry, each chapter illustrates how a particular area of biological science can benefit from the tools of informatics. The book first looks at intelligent automation, neurally based computational tools, and pharmacodynamic (PD) biomarkers. It then reviews a variety of novel technologies and approaches presently used in drug discovery at Johnson & Johnson. The text also describes how informatics can advance antibody technology and drug development for oncology. After focusing on forward genetic and reverse genetic strategies to identify relevant target genes for drug discovery, the book explains proteomic expression profiling and explores the application of laser microdissection in transcriptomics.Taking a systematic approach, this volume examines the impact of informatics tools on various areas in biopharmaceuticals by presenting in-depth analyses of emerging trends and future opportunities.Daniel E. Levy, editor of the Drug Discovery Series, is the founder of DEL BioPharma, a consulting service for drug discovery programs. He also maintains a blog that explores organic chemistry.Table of ContentsPreface. Intelligent Automation, Neurally Inspired Algorithms as Computational Tools. Using Pharmacodynamic Biomarkers to Accelerate Early Clinical Drug Development. Opportunities in CNS Drug Discovery and Development. Clinical Success of Antibody Therapeutics in Oncology. Relating Target Sequence to Biological Function. Use of Protein Microarrays for Molecular Network Analysis and Signal-Pathway Profiling. Laser Microdissection-Based Transcriptomics Using Microarrays. Index.
£170.00
Taylor & Francis Inc Structural Genomics on Membrane Proteins
Book SynopsisWhile the genomic revolution has quickly led to the deposit of more than 30,000 structures in the protein data bank (PDB), less than one percent of those contributions represent membrane proteins despite the fact that membrane proteins constitute some 20 percent of all proteins. This discrepancy becomes significantly troublesome when it is coupled with the fact that 60 percent of current drugs are based on targeting this group of proteins, a trend that does not seem likely to reverse.Structural Genomics on Membrane Proteins provides an excellent overview on novel research in bioinformatics and modeling on membranes, as well as the latest technological developments being employed in expression, purification, and crystallography to obtain high-resolution structures on membrane proteins. This cutting-edge work also explains the difficulties facing researchers—both technical and ethical—that have slowed the process. Structural Genomics on Membrane Proteins provides researchers with an unprecedented look at the novel technologies that will ultimately allow them to conquer the last frontier in structural biology, leading to accelerated breakthroughs in drug discovery.Table of ContentsIntroduction. Bioinformatics in Membrane Protein Analysis. Prokaryotic Membrane Transport Proteins: Amplified Expression and Purification. Membrane Protein Production Strategies for Structural Genomics. Refolding of Membrane Proteins for Large-scale Production. Crystallization of Membrane Proteins. Signaling through Membrane Proteins. Expression of Membrane Proteins in Yeasts. Expression of Functional Membrane Proteins in the Baculovirus-Insect Cell System: Challenges and Developments. Expression of Membrane Proteins in Mammalian Cells, Solubilization and Purification of Membrane Proteins. Fluorescent Labeling of Membrane Proteins in Living Cells. Membrane Protein NMR. Miniaturization of Structural Biology Technologies: From Expression to Biophysical Analyses. Electron and Atomic Force Microscopy of Reconstituted Membrane Proteins. Structural Genomics on Membrane Proteins. Molecular Modeling of Membrane Proteins. Towards Structural Bases for GPCR Ligand-binding: A Path for Drug Discovery.
£205.00
Humana Press Inc. Cyclooxygenases: Methods and Protocols
Book SynopsisSince the discovery of the pharmacological and toxicological importance of inhibiting the cyclooxygenase (COX) enzymes by non-steroidal anti-inflammatory drugs (NSAIDs), much research has gone into the development of methods to study the biological functions of COX-1 and COX-2. In Cyclooxygenases: Methods and Protocols, experts and pioneers in the field present the most up-to-date in vitro and in vivo techniques routinely used in COX research. The volume delves into essential topics such as the purification, cloning, and expression of COX enzymes as well as in vitro assays aimed at determining the inhibitory potency of drugs on COX-1 and COX-2 activities, with chapters describing protocols used for the extraction and measurement of the prostanoids. This volume also describes in vivo disease models used to study the roles of COX-1 and COX-2 in gastrointestinal injury, inflammation, and pain. As a book in the highly successful Methods in Molecular Biology™ series, the protocols chapters include brief introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and notes on troubleshooting and avoiding known pitfalls.Authoritative and cutting-edge, Cyclooxygenases: Methods and Protocols serves as an indispensable tool for all scientists seeking the treatment of inflammation, pain, fever, and other harmful conditions.Table of ContentsPart I: In vitro Protocols for Studying Expression and Activity of Cyclooxygenase Enzymes and Characterisation of Their Inhibition Patterns 1. In vitro Expression and Activity Protocols: Introduction to Part I Roderick J. Flower 2. Techniques Used to Study Regulation of Cyclooxygenase-2 Promoter Sites Hiroyasu Inoue and Rieko Nakata 3. Purification of Recombinant Human COX-1 and COX-2 James K. Gierse 4. Cloning and Expression of Cyclooxygenase-1 and Cyclooxygenase-2 Nicholas R. Staten and Beverly A. Reitz 5. Expression of Cyclooxygenase Isoforms in the Baculovirus Expression System John C. Hunter, Natalie M. Myres, and Daniel L. Simmons 6. Peroxidase Active Site Activity Assay Kelsey C. Duggan, Joel Musee, and Lawrence J. Marnett 7. Study of Inhibitors of the PGH Synthases for which Potency is Regulated by the Redox State of the Enzymes Olivier Boutaud and John A. Oates 8. Different Methods for Testing Potential Cyclooxygenase-1 and Cyclooxygenase-2 Inhibitors Stefan Laufer and Sabine Luik 9. In vitro Cyclooxygenase Activity Assay in Tissue Homogenates Samir S. Ayoub 10. Techniques Used to Characterize the Binding of Cyclooxygenase Inhibitors to the Cyclooxygenase Active Site William F. Hood 11. In vitro Assays for Cyclooxygenase Activity and Inhibitor Characterization Mark C. Walker and James K. Gierse Part II: Extraction and Measurement of Prostanoids and Isoprostanes 12. Extraction and Measurement of Prostanoids and Isoprostanes: Introduction to Part II Paola Patrignani 13. Prostanoid Extraction and Measurement Lorenzo Polenzani and Samir S. Ayoub 14. Measurement of 8-iso-prostagnadin F2a in Biological Fluids as a Measure of Lipid Peroxidation Stefania Tacconelli, Marta L. Capone, and Paola Patrignani Part III: In vivo Models to Study Involvement of Cyclooxygenase Products in Health and Disease 15. In vivo Models to Study Cyclooxygenase Products in Health and Disease: Introduction to Part III Derek W. Gilroy, Melanie Stables, and Justine Newson 16. Protocols to Assess the Gastro-Intestinal Side Effects Resulting from Inhibition of Cyclo-Oxygenase Isoforms Brendan J.R. Whittle 17. Cyclooxygenase Enzymes and Their Products in the Carragenaan-Induced Pleurisy in Rats Adrian R. Moore, Samir S. Ayoub, and Michael P. Seed 18. Iloprost-Induced Nociception: Determination of the Site of Anti-Nociceptive Action of Cyclooxygenase Inhibitors and the Involvement of Cyclooxygenase Products in Central Mechanisms of Nociception Samir S. Ayoub and Regina M. Botting
£999.99
Thieme Medical Publishers Inc Thieme Test Prep for the USMLE®: Learning
Book SynopsisLearning Pharmacology through Clinical Cases by Mario Babbini and Sandeep Bansal uniquely integrates the preclinical disciplines, which is crucial for pharmacological problem solving and learning to think critically. Each case portrays a real-life scenario, promoting a bridge from foundational knowledge to its application. A series of USMLE-style questions with thorough explanations guide the reader through a comprehensive understanding of relevant basic science disciplines such as physiology, pathology, and microbiology, followed by a detailed analysis of the pharmacology. Key Features Nearly 50 case studies mirror situations seen in every-day practice In-depth coverage of drugs in the context of specific disease states and clinical situations Comprehensive cases encompass medical/family/drug history, physical examination, lab findings, diagnosis, pharmacotherapy, and follow-up One set of multiple choice questions addresses related basic science content. A second set covers topics related to the pharmacology, such as mechanism of action, adverse effects, and contraindications. This essential, highly practical resource will help medical students build problem-solving skills, assess pharmacology knowledge, and fully prepare for board examinations.Table of Contents1 Acromegaly 2 Acute Lymphoblastic Leukemia 3 Asthma 4 Atrial Fibrillation 5 Bipolar Disorder 6 Breast Cancer 7 Cardiogenic Shock 8 Crohn's Disease 9 Chronic Kidney Disease 10 Chronic Obstructive Pulmonary Disease 11 Drug Abuse 12 Epilepsy 13 Essential Hypertension 14 General Anesthesia 15 Glaucoma 16 Gout 17 Graves' Disease 18 Growth Retardation and Hypogonadism 19 Heart Failure 20 Hematopoietic Cell Transplantation 21 Hodgkin's Lymphoma 22 Hormonal Contraception 23 Human Immunodeficiency Virus Infection 24 Infective Endocarditis 25 Iron Deficiency Anemia 26 Liver Cirrhosis 27 Lung Cancer 28 Megaloblastic Anemia 29 Migraine 30 Myasthenia Gravis 31 Myocardial Infarction 32 Parkinson's Disease 33 Peptic Ulcer Disease 34 Perimenopause and Osteoporosis 35 Pheochromocytoma 36 Pneumonia 37 Polycystic Ovarian Syndrome 38 Primary Adrenal Deficiency (Addison's Disease) 39 Prostate Cancer 40 Psoriasis 41 Pulmonary Embolism 42 Rheumatoid Arthritis 43 Schizophrenia 44 Solid Organ Transplantation 45 Stroke 46 Systemic Lupus Erythematosus 47 Torsade de Pointes 48 Type 1 Diabetes Mellitus 49 Type 2 Diabetes Mellitus 50 Urinary Tract Infection
£47.00
Independently Published Alcohol and Drug Counselor Exam Practice
Book Synopsis
£14.45
Apple Academic Press Inc. Recent Advances in Plant-Based, Traditional, and
Book SynopsisThe purpose of this book is to discuss several medicinal plants to find wider application in the domain of medicinal, clinical, and pharmaceutical treatment. Recent Advances in Plant-Based, Traditional, and Natural Medicines serves as a useful source of ideas and an inspiration for further cell and molecular biology research toward developing drugs and treatments from these traditional and plant-based remedies.The book covers a variety of topics and:• Considers the current state of research of traditional and plant-based medicines• Covers the current status of ethnomedicine and medicinal plant discovery• Presents the clinical applications of traditional and plant-based medicinesTable of ContentsIntroduction; Part 1: Relevance of Traditional Knowledge to Biological Testing; The Relevance of Traditional Knowledge Systems for Ethnopharmacological Research: Theoretical and Methodological Contributions; Victoria Reyes-García; Antioxidative and in vitro Antiproliferative Activity of Arctium lappa Root Extracts; Fabricia S. Predes, Ana L.T.G Ruiz, João E. Carvalho, Mary A. Foglio, and Heidi Dolder; Interleukin-6 and Cyclooxygenase-2 Down-regulation by Fatty-Acid Fractions of Ranunculus constantinopolitanus; Sabreen F. Fostok, Rima A. Ezzeddine, Fadia R. Homaidan, Jamal A. Al-Saghir, Ralph G. Salloum, Najat A. Saliba, and Rabih S. Talhouk; An Extract of the Medicinal Mushroom Agaricus blazei Murill Can Protect Against Allergy; Linda K. Ellertsen and Geir Hetland; Anti-Oxidative Effects of the Biennial Flower of Panax notoginseng Against H2O2-Induced Cytotoxicity in Cultured PC12 Cells; Roy Chi-Yan Choi, Zhiyong Jiang, Heidi Qun Xie, Anna Wing-Han Cheung, David Tai-Wai Lau, Qiang Fu, Tina Tingxia Dong, Jijun Chen, Zhengtao Wang, and Karl Wah-Keung Tsim; Cytotoxic Activity of Proteins Isolated from Extracts of Corydalis cava Tubers in Human Cervical Carcinoma HeLa Cells; Robert Nawrot, Maria Wolun-Cholewa, Wojciech Bialas, Danuta Wyrzykowska, Stanislaw Balcerkiewicz, and Anna Gozdzicka-Jozefiak; Arctigenin from Arctium lappa Inhibits Interleukin-2 and Interferon Gene Expression in Primary Human T Lymphocytes; Wei-Jern Tsai, Chu-Ting Chang, Guei-Jane Wang, Tzong-Huei Lee, Shwu-Fen Chang, Shao-Chun Lu, and Yuh-Chi Kuo; Part 2: Targeting Important Diseases Using Natural Products (TK or non-TK based); A New Dawn for the Use of Traditional Chinese Medicine in Cancer Therapy; Harendra S. Parekh, Gang Liu, and Ming Q. Wei; Anti Cancer Effects of Curcumin: Cycle of Life and Death; Gaurisankar Sa and Tanya Das; Comparative Study of the Antioxidant and Reactive Oxygen Species Scavenging Properties in the Extracts of the Fruits of Terminalia chebula, Terminalia belerica, and Emblica officinalis; Bibhabasu Hazra, Rhitajit Sarkar, Santanu Biswas, and Nripendranath Mandal; Inhibition of Highly Productive HIV-1 Infection in T cells, Primary Human Macrophages, Microglia, and Astrocytes by Sargassum fusiforme; Elena E. Paskaleva, Xudong Lin, Wen Li, Robin Cotter, Michael T. Klein, Emily Roberge, Er K. Yu, Bruce Clark, Jean-Claude Veille, Yanze Liu, David Y-W Lee, and Mario Canki; Part 3: Molecular Biology, Genomics, and Proteomics: Plant Centered and Person Centered; The Use of Phylogeny to Interpret Cross-Cultural Patterns in Plant Use and Guide Medicinal Plant Discovery: An Example from Pterocarpus (Leguminosae); C. Haris Saslis-Lagoudakis, Bente B. Klitgaard, Félix Forest, Louise Francis, Vincent Savolainen, Elizabeth M. Williamson, and Julie A. Hawkins; Ethnobotany Genomics: Discovery and Innovation in a New Era of Exploratory Research; Steven G. Newmaster and Subramanyam Ragupathy; Prescriptions of Traditional Chinese Medicine Are Specific to Cancer Types and Adjustable to Temperature Changes; Pei-Hsun Chiu, Hsin-Ying Hsieh, and Sun-Chong Wang; Part 4: Personalized or Person-Centered Medicine; Traditional, Complementary, and Alternative Medical Systems and Their Contribution to Personalization, Prediction, and Prevention in Medicine: Person-Centered Medicine; Paolo Roberti di Sarsina, Mauro Alivia, and Paola Guadagni; Index
£108.00
Apple Academic Press Inc. Chemometrics Applications and Research: QSAR in
Book SynopsisThis important new book provides innovative material, including peer-reviewed chapters and survey articles on new applied research and development, in the scientifically important field of QSAR in medicinal chemistry. QSAR is a growing field because available computing power is continuously increasing, QSAR’s potential is enormous, limited only by the quantity and quality of the available experimental input, which are also continuously improving. The number of possible structures for the design of new organic compounds is difficult to imagine, and QSAR helps to predict their activities even before synthesis.The book provides a wealth of valuable information and: • Presents an overview of recent developments in QSAR methodologies along with a brief history of QSAR• Covers the available web resource tools and in silico techniques used in virtual screening and drug discovery processes, compiling an extensive review of web resources in the following categories: databases related to chemical compounds, drug targets, and ADME/toxicity prediction; molecular modeling and drug designing; virtual screening; pharmacophore generation; molecular descriptor calculation software; software for quantum mechanics; ligand binding affinities (docking); and software related to ADME/toxicity prediction• Reviews the rm2 as a more stringent measure for the assessment of model predictivity compared to traditional validation metrics, being specifically important since validation is a crucial step in any QSAR study• Presents linear model improvement techniques that take into account the conformation flexibility of the modeled molecules• Summarizes the building processes of four different pharmacophore models: common-feature, 3D-QSAR, protein-, and protein-ligand complexes• Shows the role of different conceptual density functional theory based chemical reactivity descriptors, such as hardness, electrophilicity, net electrophilicity, and philicity in the design of different QSAR/QSPR/QSTR models• Reviews the use of chemometrics in PPAR research highlighting its substantial contribution in identifying essential structural characteristics and understanding the mechanism of action• Presents the structures and QSARs of antimicrobial and immunosuppressive cyclopeptides, discussing the balance of antimicrobial and haemolytic activities for designing new antimicrobial cyclic peptides• Shows the relationship between DFT global descriptors and experimental toxicity of a selected group of polychlorinated biphenyls, exploring the efficacy of three DFT descriptors• Reviews the applications of Quantitative Structure-Relative Sweetness Relationships (QSRSR), showing that the last decade was marked by an increase in the number of studies regarding QSAR applications for both understanding the sweetness mechanism and synthesizing novel sweetener compounds for the food additive industryThe wide coverage makes this book an excellent reference for those in chemistry, pharmacology, and medicine as well as for research centers, governmental organizations, pharmaceutical companies, and health and environmental control organizations.Trade Review"This concisely written and up-to-date book is an asset for QSAR, and it will create great interest among the new entrants into the field. It covers topics from 2D-to 6D-QSAR and allied topics in good details with high clarity. The book deserves high place on the desks of beginners and practicing professionals."—Vijay Masand, PhD, Department of Chemistry, Vidya Bharati College, Amravati, Maharashtra, IndiaTable of ContentsPreface. Overview and Recent Advances in QSAR Studies. Software and Web Resources for Computer-Aided Molecular Modeling and Drug Discovery. The Rm2 Metrics for Validation of QSAR/QSPR Models. Considering the Molecular Conformational Flexibility in QSAR Studies. Practical Aspects of Building, Validation and Application of 3D-Pharmacophore Models. Application of Conceptual Density Functional Theory in Developing QSAR Models and Their Usefulness in the Prediction of Biological Activity and Toxicity of Molecules. Synopsis of Chemometric Applications to Model PPAR Agonism. Antimicrobial and Immunosuppressive Activitites of Cyclopeptides as Targets for Medicinal Chemistry. On the Use of Quantitative Structure Activity Relationships (QSAR) and Global Reactivity Descriptors to Study the Biological Activities of Polychlorinated Biphenyls (PCBs). Applications of Quantitative Structure-Relative Sweetness Relationships in Food Chemistry. QSAR Studies of 1, 4-Benzodiazepines as CCKA Antagonist. Docking-Based Scoring Parameters Based QSAR Modeling on a Dataset of Bisphenylbenzimidazole as Non-Nucleoside Reverse Transcriptase Inhibitor. Potential Anti-Inflammatory and Anti-Proliferative Agents.-1h-Isochromen-1-Ones and Their Thio Analogues and Their QSAR Studies. QSAR Studies on Dihydrofolate Reductase Enzyme: From Model to Biological Activity. Index.
£121.50
Apple Academic Press Inc. Alginates: Versatile Polymers in Biomedical
Book SynopsisThis new volume explores the latest research on the use of alginate as a biopolymer in various biomedical applications and therapeutics. The uses of alginates and modified alginates discussed in this book include tissue regeneration, encapsulation and delivery of drugs, nucleic acid materials, proteins and peptides, genes, herbal therapeutic agents, nutraceuticals, and more. This book also describes the synthesis and characterizations of various alginate and modified alginate systems, such as hydrogels, gels, composites, nanoparticles, scaffolds, etc., used for the biomedical applications and therapeutics. Alginate, a biopolymer of natural origin, is of immense interest for its variety of applications in pharmaceuticals (as medical diagnostic aids) and in materials science. It is the one of the most abundant natural biopolymers and is considered an excellent excipient because of its non-toxic, stable, and biodegradable properties. Several research innovations have been made on applications of alginate in drug delivery and biomedicines. There needs to be a thorough understanding of the synthesis, purification, and characterization of alginates and its derivatives for their utility in healthcare fields, and this volume offers an abundance of information toward that end.Table of Contents1. Alginates: Source, Chemistry, and Properties 2. Recent Advances of Alginates as Material for Biomedical Applications 3. Alginates: Hydrogels, their Chemistry, and Applications 4. Alginate-Based Hydrogels: Synthesis, Characterization, and Biomedical Application 5. Chemically Modified Alginates for Advanced Biomedical Applications 6. Bionanocomposites of Alginates, their Chemistry, and Applications 7. Alginate and its Applications in Tissue Engineering 8. Alginate-Based Scaffolds in Bone Tissue Engineering Applications 9. Alginate Properties, Pharmaceutical and Tissue Engineering Applications 10. Alginate: Drug Delivery and Application 11. Chemical and Physical Modifications of Alginate to Improve their use as Carriers in Delivery Systems 12. Updates on Alginate-Based Interpenetrating Polymer Networks for Sustained Drug Release 13. Alginate Nanoparticles 14. Alginate-Based Nanocarriers in Modern Therapeutics 15. Alginate-Based Composites in Drug Delivery Applications 16. Hydroxyapatite-Alginate Composites in Drug Delivery 17. Alginate-Based Gastrointestinal Tract Drug Delivery Systems 18. Alginate Hydrogels as a Colon-Targeted Drug Delivery System 19. Alginate Carriers for Treatment of Ocular Diseases 20. Alginate Carriers for Bioactive Substances: Herbal Natural Compounds and Nucleic Acid Materials
£183.35
Apple Academic Press Inc. Natural Polymers for Pharmaceutical Applications
Book SynopsisPolymers of natural origins have been explored for their variety of uses and applications in pharmaceuticals, medical diagnostic aids, and materials science. In nature, a huge quantity of natural polymers is obtained from different sources such as plants, animals, and also from marine environments. These are abundantly present in nature and are considered excellent excipients because of their nontoxic, stable, and biodegradable properties. Natural Polymers for Pharmaceutical Applications (3-volume set) discusses the research innovations that have been made on applications of natural polymers in drug delivery and biomedicines. Volume 1 focuses on plant-derived polymers, while volume 2 covers marine- and microbiologically derived polymers. Volume 3 looks at polymers derived from animal sources.These three volumes provide a thorough exploration into natural polymers chemistry, including collection, chemical modifications, characterizations, and applications of na
£312.30
Apple Academic Press Inc. Natural Polymers for Pharmaceutical Applications:
Book SynopsisThis new volume, Natural Polymers for Pharmaceutical Applications, Volume 1: Plant-Derived Polymers, presents some of the latest research on the applications of natural polymers in drug delivery and therapeutics for healthcare benefits. Polymers and their applications from several plants are discussed in depth, including tamarind gum, gum Arabic, natural carbohydrate polymer gum tragacanth, pectin, guar gum and its derivatives, locust bean gum, sterculia gum, okra gum, and others. The use of the polymers derived from plants as potential pharmaceutical excipients is expanding day by day because of their stability in the biological system, drug-releasing capability, drug-targeting abilities, as well as their bioavailability. Trade Review“A well-engrossed concept on application of natural plant derivatives as pharmaceutical additives. . . . The superlative collection on the application of plant derivatives in design of novel drug delivery systems, such as micro and nanoparticles, throws an insight on the useful applications of plant-derived products. I would say with a definite certitude that the book will prove to be an exemplary reference for academicians and scientist working in the field of plant-derived products for pharmaceutical applications.” - Dr. Tahir Ansari, Assistant Professor, University of Kualalumpur, MalaysiaTable of ContentsVolume 1: Plant-Derived Polymers 1. Pharmaceutical Applications of Tamarind Gum 2. Pharmaceutical Applications of Gum Arabic 3. Recent Advances in Pharmaceutical Applications of Natural Carbohydrate Polymer Gum Tragacanth 4. Application Potential of Pectin in Drug Delivery 5. Guar Gum and Its Derivatives: Pharmaceutical Applications 6. Pharmaceutical Applications of Locust Bean Gum 7. Pharmaceutical Applications of Sterculia Gum 8. Pharmaceutical Applications of Okra Gum 9. Pharmaceutical Applications of Fenugreek Seed Gum
£117.80
Apple Academic Press Inc. Natural Polymers for Pharmaceutical Applications:
Book SynopsisMany polymers derived from various marine sources and microorganisms possess some important biological properties such as biocompatibility, biodegradability, and bioadhesivity that make them attractive as pharmaceutical excipients in various pharmaceutical dosage forms. Moreover, these polymers can be modified physically and/or chemically to improve their biomaterial properties.In this volume, Natural Polymers for Pharmaceutical Applications, Volume 2: Marine- and Microbiologically Derived Polymers, looks at how these polymers have been explored and exploited for pharmaceutical uses, such as in tablets, microparticles, nanoparticles, ophthalmic preparations, gels, emulsions, suspensions, etc. Some commonly used marine- and microbiologically derived polymers used as pharmaceutical excipients include alginates, agar-agar, gellan gum, carrageenan; chitosan, xanthan gum, and others. The book focuses on important recent advances from experts around the world on marine-derived polysaccharides and pharmaceutical applications of alginates, agar-agar, gellan gum, carrageenan, chitosan derivatives, xanthan gum. Table of ContentsVolume 2: Marine- and Microbiologically Derived Polymers 1. Marine-Derived Polysaccharides: Pharmaceutical Applications 2. Pharmaceutical Applications of Alginates 3. Pharmaceutical Applications of Agar-Agar 4. Pharmaceutical Applications of Gellan Gum 5. Pharmaceutical Applications of Carrageenan 6. Pharmaceutical Application of Chitosan Derivatives 7. Pharmaceutical Applications of
£117.80
CABI Publishing Natural Polymers for Drug Delivery
Book SynopsisNatural polymers have been utilized extensively in food, pharmaceuticals, cosmetics, textiles, oil drilling and paint industries. Their non-toxic and inexpensive attributes readily enhance their commercial acceptability and make them potent agents in lieu of synthetic polymers. This book explores the opportunistic utility of natural polymers in developing effective drug delivery systems and provides a comprehensive and up-to-date analysis of their source, chemical structure and mechanism of action. Covering novel polymers for drug delivery - in particular extracts from plants, microorganisms and proteins, as well as water soluble and water insoluble biodegradable polymers - it presents an encyclopaedic overview of natural polymers': - quintessential roles in binding drugs towards enhancing bioavailability - modification and derivatization for targeted delivery - role as active drugs Natural Polymers for Drug Delivery is an invaluable resource for researchers, students and industrial scientists in the fields of biochemistry, chemistry, pharmacology and food science.Table of Contents1: Natural Polymers for Drug Delivery: An Introduction Section I: Drug Delivery Based on Different Classes of Polymers 2: Cellulose-based Polymeric Systems in Drug Delivery 3: Hydrocolloids-based Hydrogels in Drug Delivery 4: Water Soluble Biodegradable Polymers for Drug Delivery 5: Polysaccharide-based Drug Carriers 6: Polymer-based Nanoparticles for Drug Delivery Systems and Cancer Therapeutics 7: Polymer Nanocomposite-based Biosensors for Drug Delivery Applications Section II: Polymeric Interaction and Conjugates 8: Polymer-Drug Conjugates: Targeted Drug Delivery 9: Protein-Drug Conjugates: A New Class of Biotherapeutics 10: Microencapsulation for Controlled Gastrointestinal Delivery of Probiotics and Prebiotics Section III: Disease-specific Drug Delivery Systems 11: Chitosan in Drug Delivery and Targeting for Cancer Treatment 12: Polymers as Biodegradable Matrices in Transdermal Drug Delivery 13: Ocular Drug Delivery Systems 14: Natural Polymers Targeting Habitual Disease 15: Bioengineered Wound and Burn Healing Substitutes: Novel Design for Biomedical and General Applications
£99.76
CABI Publishing Antimicrobial Peptides: Discovery, Design and
Book SynopsisAntimicrobial peptides (AMPs) have attracted extensive research attention worldwide. Harnessing and creating AMPs synthetically has the potential to help overcome increasing antibiotic resistance in many pathogens. This new edition lays the foundations for studying AMPs, including a discovery timeline, terminology, nomenclature and classifications. It covers current advances in AMP research and examines state-of-the-art technologies such as bioinformatics, combinatorial libraries, high-throughput screening, database-guided identification, genomics and proteomics-based prediction, and structure-based design of AMPs. Thoroughly updated and revised, this second edition contains new content covering: defensins; cathelicidins; anti-MRSA, antifungal, antiviral, anticancer and antibiofilm strategies; combined treatments; adjuvants in vaccines; advances in AMP technologies that cover surface coating to prevent biofilm formation; nanofiber encapsulation technologies for delivery and sustained release; and understanding innate immunity and the basis for immune boosting to overcome obstacles in developing AMPs into therapeutic agents. Written and reviewed by a group of established investigators in the field, Antimicrobial Peptides is a valuable resource for postgraduate students, researchers, educators, and medical and industrial personnel.Table of ContentsPART I: OVERVIEW OF ANTIMICROBIAL PEPTIDES 1: Discovery, Classification and Functional Diversity of Antimicrobial Peptides PART II: NATURAL TEMPLATES FOR PEPTIDE ENGINEERING 2: Structural and Functional Diversity of Cathelicidins 3: Disulfide-linked Defensins and Their Therapeutic Potential 4: Lantibiotics: Bioengineering and Applications PART III: EXPANDING PEPTIDE SPACE: COMBINATORIAL LIBRARY, GENOME-BASED PREDICTION AND DE NOVO DESIGN 5: Discovery of Novel Antimicrobial Peptides Using Combinatorial Chemistry and High-throughput Screening 6: Prediction and Design of Antimicrobial Peptides: Methods and Applications to Genomes and Proteomes PART IV: MECHANISMS OF ACTION: BIOPHYSICS AND STRUCTURAL BIOLOGY 7: Antimicrobial Peptides: Multiple Mechanisms Against a Variety of Targets 8: Microbial Membranes and the Action of Antimicrobial Peptides 9: Non-membranolytic Mechanisms of Action of Antimicrobial Peptides – Novel Therapeutic Opportunities? 10: Structural Insight into the Mechanisms of Action of Antimicrobial Peptides and Structure-based Design PART V: NOVEL THERAPEUTIC STRATEGIES: SYNERGY, IMMUNE MODULATION, SURFACE COATING, AND DELIVERY 11: Synergy of Antimicrobial Peptides 12: Surface Immobilization of Antimicrobial Peptides to Prevent Biofilm Formation 13: Sustained Delivery of Cathelicidin Antimicrobial Peptide-Inducing Compounds to Minimize Infection and Enhance Wound Healing 14: Immunomodulatory Activities of Cationic Host Defence Peptides and Novel Therapeutic Strategies
£106.70
Jessica Kingsley Publishers Essential Oils (Fully Revised and Updated 3rd
Book SynopsisRevised and significantly expanded, the latest edition of this handbook provides full information on the use of essential oils in the field of contemporary aromatherapy and aromatic therapy, based on the most up-to-date research evidence behind their therapeutic applications.The third edition features a fully updated and expanded contents including detailed Aromatic Profiles of over 250 essential oils, absolutes and resinoids, a new chapter on the latest research in pharmacognosy to foster an understanding of how essential oils work, and a new chapter on formulating essential oils, based on theory and evidence and containing practical suggestions. The author provides a detailed account of how essential oils are created, how and where aromatherapy is used, and the underlying pharmacology and chemistry. This will be an indispensable text for all students and practitioners of aromatherapy and related disciplines, as well as anyone interested in the use of essential oils for health and well-being.To access an updated table of contents and index, please see the 'Resources' section at this link: www.singingdragon.com/catalogue/book/9781787752290Trade ReviewA brilliant piece of work! Jennifer is a dedicated writer who helps us think more clearly about essential oils. I stand in awe of her impressive wisdom. Over the last 25 years as an aromatherapy educator, I have found myself reaching for Jennifer's books, over and over again. I am delighted to have her beautiful book. Definitely a gem to be treasured among your Aromatherapy books! -- Andrea Butje, aromatherapy educator and authorI'm impressed by the new edition of Essential Oils. It's a whole new book and not just an updated glance over previous editions. The most salient update is an entirely new section on essential oil pharmacology, and profiles of individual constituents. Another valuable addition is Jennifer's practical guidance on how to translate scientific findings into therapeutic practice. Essential Oils is a comprehensive source of knowledge for anyone wishing to take a deep dive into all aspects of aromatherapy, supported by recent research. I have no doubt it will reach the status of aromatherapy's textbook that we didn't have so far. -- Petra Ratajc PhD, biologist, researcher, educatorWith over 2,000 references, Dr Rhind's comprehensive new edition will delight and inspire both scientific and intuitively-minded people. The evidence-based chapters on aromatic pharmacognosy and component profiles and the chapter and appendix on individualised prescriptions and aromatic formulations for different conditions provide a welcome guideline for health practitioners and members of the general public wanting to use essential oils safely for many common ailments. -- Dr E. Joy Bowles, PhD, BSc, author of “The Chemistry of Aromatherapeutic Oils”This is a truly fantastic update to the 1st and 2nd editions. The new inclusions are wonderful and make for essential reading for the aromatherapist. I am extremely excited to introduce this book to our students at Moray College UHI, from those studying at Higher National level to those undertaking Intensive Aromatic studies in the honours year of the BSC Integrative Healthcare. This remarkable book will be an essential core text for both the student and the practising therapist alike. -- Lesley Ann Potter, Lecturer – HNC/D Complementary Therapies & BSc (hons) Integrative HealthcareJennifer Rhind does it again and better than ever! A captivating and thoroughly enjoyable read. From history of aromatics in their various forms to the scientific research we have to date, Jennifer delivers a comprehensive examination of the evolution of medicamentum and its relevance in aromatic therapies today. This prodigious book is a valuable resource to foster the continuing education of the serious practitioner and inspires the reader to dig deeper and explore all the various aspects from olfaction and the psyche to formulary of the healing art and science that is Aromatherapy. -- Lora Cantele, RA, APAIA, Cert. Aromflexologist Editor/Publisher of the International Journal of Professional Holistic AromatherapyThis uniquely comprehensive reference book expands and advances one's understanding of aromatherapy. Jennifer Peace Rhind adeptly draws from a plethora of scholarly sources and scientific research to deepen our knowledge of essential oils and the activities of their individual chemical components. Her singularly meticulous approach is equally distinguished by thorough investigations into the biology, ecology, history and ethnobotany of aromatic plants as well as the therapeutic uses of their extracts. Further equipped with practical guidelines and formulas, this book is a must for aromatherapy enthusiasts and professionals alike. -- Dr. Kelly Ablard, PhD,RA,EOT, Director, Airmid Institute; Co-owner, Essence of Thyme College of Holistic Studies
£73.15
IntechOpen Metformin: Pharmacology and Drug Interactions
Book SynopsisType 2 diabetes (T2D), also known as non-insulin-dependent diabetes mellitus (NIDDM), is a condition in which cells fail to respond to insulin properly. As the disease progresses, the body does not produce enough insulin. There are several classes of anti-diabetic medications available, including the oral agent metformin. This medication is recommended as first-line treatment for T2D, except for those patients with severe kidney or liver problems. This book discusses the molecular mechanism, pharmacokinetics, and uses of metformin, as well as presents information on adverse drug reactions, drug interactions, and the potential use of metformin in tuberculosis.
£89.25
Taylor & Francis Ltd Multiple Sclerosis Therapeutics
Book SynopsisSince the publication of the previous edition of this volume, there has been substantial progress in a number of areas of multiple sclerosis (MS) research. Although immunosuppressive treatments continue to be developed and refined, more targeted immunomodulatory therapies are surfacing as we learn more about how the immune system works in health and disease.Multiple Sclerosis Therapeutics, Third Edition provides a comprehensive review of clinical trial methodology and therapeutic modalities in MS. This edition reflects current understanding of the pathophysiology of the disease and includes popular and emerging treatments. Topics include: Biomarkers in MS Pharmacogenomics Emerging therapeutic modalities such as natalizumab, T-cell-based and B-cell-based therapies, cytokine/chemokine-based therapies, statins, and 4-aminopyridine Neuroprotection The use of OCT and MRI to guide disease therapy Within the next several years, we will begin to discover the utility and the limitations of stem cells in the treatment of MS. It is likely that the next edition of this text will include clinical trial data that evaluate early attempts at nervous system regeneration in MS. Until that time occurs, this volume remains an essential resource for neurologists and anyone involved in the treatment of MS.Table of Contents1. Aspects of multiple sclerosis that relate to trial design and clinical management. 2. Biological concepts of multiple sclerosis pathogenesis and relationship to treatment. 3. The multiple sclerosis disease process as characterized by magnetic resonance imaging. 4. Measures of neurological impairment and disability in multiple sclerosis. 5. Assessment of neuropsychological function in multiple sclerosis. 6. Health-related quality of life assessment in multiple sclerosis. 7. Measures of gadolinium enhancement, T1 black holes and T2-hyperintense magnetic resonance imaging in multiple sclerosis. 8. Measures of magnetization transfer in multiple sclerosis. 9. Measurement of central nervous system atrophy in multiple sclerosis. 10. Axonal pathology in patients with multiple sclerosis: evidence from in vivo proton magnetic resonance spectroscopy. 11. Functional imaging in multiple sclerosis. 12. Magnetic resonance imaging of pathway-specific structure and function in multiple sclerosis. 13. Optical coherence tomography to monitor neuronal integrity in multiple sclerosis. 14. Biomarkers in multiple sclerosis. 15. The process of drug development and approval inthe United States, the European Union and Canada. 16. Selection and interpretation of end-points in multiple sclerosis clinical trials. 17. Clinical trial logistics. 18. The challenge of long-term studies in multiple sclerosis: use of pooled data, historical controls and observational studies to determine efficacy. 19. Alternative designs for multiple sclerosis clinical trials. 20. Ethical considerations in multiple sclerosis clinical trials. 21. Pharmacogenetics and pharmacogenomics in multiple sclerosis. 22. Interferons in relapsing.remitting multiple sclerosis. 23. Interferons in secondary progressive multiple sclerosis. 24. Neutralizing antibodies directed against interferon A. 25. Glatiramer acetate as therapy for multiple sclerosis. 26. Use of mitoxantrone to treat multiple sclerosis. 27. Use of cyclophosphamide and other immunosuppressantsto treat multiple sclerosis. 28. Natalizumab in multiple sclerosis. 29. High-dose methylpredisolone in the treatment of multiple sclerosis. 30. Intravenous immunoglobulin in multiple sclerosis. 31. Therapeutic plasma exchange for multiple sclerosis. 32. Statins in multiple sclerosis. 33. Stem cell transplantation for multiple sclerosis. 34. T cell-based therapies in multiple sclerosis. 35. B cell-based therapies for multiple sclerosis and related diseases. 36. Chemokines and central nervous system inflammation: relevance to multiple sclerosis. 37. Sex hormones and other pregnancy-related factors with therapeutic potential in multiple sclerosis. 38. Neuroprotection in multiple sclerosis. 39. Combination therapy in multiple sclerosis. 40. Fampridine in multiple sclerosis. 41. Complementary and alternative treatments in multiple sclerosis. 42. Disease-modifying therapy for multiple sclerosis in clinical practice. 43. Treatment for patients with primary progressive multiple sclerosis. 44. Use of magnetic resonance imaging in clinical management of multiple sclerosis. 45. Fatigue in multiple sclerosis. 46. Management of spasticity in multiple sclerosis. 47. Management of bladder and sexual dysfunction in multiple sclerosis. 48. Depression in multiple sclerosis. 49. Treatment of pain, paresthesias and paroxysmal disorders in multiple sclerosis. 50. Rehabilitation in multiple sclerosis patients.
£256.50
Taylor & Francis Ltd Principles of Toxicology Testing
Book SynopsisNationally, toxicology programs have evolved from a traditional exploration of the chemistry and applied toxicity of chemicals and drugs to a more comprehensive study of toxicology and toxicology testing as independent entities. Consequently, the second edition of Principles of Toxicology Testing starts with basic toxicological principles, including absorption, distribution, metabolism, and elimination of toxins, including chemicals and drugs. The book then continues with animal (in vivo) and in vitro toxicology testing methods associated with toxicological analysis and preclinical drug development. As in the first edition, the book begins with an introduction into the fundamentals of toxicology (Section I) to prepare readers for the subsequent topics and continues through with a discussion of toxicokinetics and human risk assessment. This introductory material is useful in understanding the applications of toxicology testing.Section II describes the fundamental principles of toxicology testing in animals in greater detail. This section describes acute toxicity studies as well as subchronic and chronic studies performed on animals. Special emphasis is placed on study design and determination of classical indicators for acute and chronic testing, such as the LD50. The book examines other short- and long-term animal toxicity testing methodologies, including dermal, ocular, and reproductive toxicity testing. In addition, mutagenicity and carcinogenicity studies are also discussed in separate chapters.Section III introduces and discusses in vitro alternatives to animal toxicology tests. This section emphasizes cell culture methodology and cellular methods for acute systemic toxicity, target organ toxicity, and local toxicity. The contributors present the advantages and disadvantages of alternative methods. They also describe the use of high-throughput screening and its applications, the concepts of standardization and validation of in vitro techniques (especially large, organized validation efforts currently supported by US and EU regulatory agencies), and the theories supporting the development of in vitro methodologies. This second edition is a must-read for undergraduate and graduate toxicology students. Industrial and academic research centers will also find the text useful for establishing a toxicology testing laboratory.Trade Review"This book comprises 23 chapters in three sections: basic concepts; testing in vivo; and testing in vitro, laid out in clear typeface with excellent illustrations and diagrams … Culture and test procedures or protocols are clearly laid out in a flow diagram format that seem easy to follow."—Adam Woolley ForthTox, UK in bst News"This book comprises 23 chapters in three sections: basic concepts; testing in vivo; and testing in vitro, laid out in clear typeface with excellent illustrations and diagrams … Culture and test procedures or protocols are clearly laid out in a flow diagram format that seem easy to follow."—Adam Woolley ForthTox, UK in bst NewsTable of ContentsBasic Concepts in Toxicology Testing. Introduction to Principles of Toxicology Testing. Effects of Chemicals. Toxicokinetics. Risk Assessment and Regulatory Toxicology. Descriptive Animal Toxicology Tests. Toxicology Testing in Vivo. Acute Toxicology Testing. Subchronic and Chronic Toxicology Testing. Acute Dermal Toxicology Testing. Acute Ocular Toxicology Testing. Toxicity Testing for Fertility and Reproduction. Carcinogenicity and Mutagenicity Testing in Vivo. Toxicology Testing in Vitro. Introduction to In Vitro Toxicology Testing. Cell Culture Methodology. Cell Culture Methods for Acute Toxicology Testing. Acute Local Toxicology Testing in Vitro. Toxicokinetic Studies in Vitro. Mutagenicity and Carcinogenicity Testing in Vitro. Reproductive and Teratogenicity Studies in Vitro. High Throughput Screening and Microarray (MA) Analysis. Toxicogenomics and Epigentic Testing in Vitro. Experimental Design and Statistics. Applications of Alternative Models for Toxicology Testing.
£123.50
CABI Publishing Botanical Medicine in Clinical Practice
Book SynopsisThe potential benefits of plants and plant extracts in the treatment and possible prevention of many leading health concerns are becoming more widely recognised within the medicinal community. This major comprehensive reference work contains contributions from more than 80 clinical and academic experts in the field, covering a range of plant products and their uses, divided into sections on topics such as treatments of cardiovascular diseases and cancer. The book covers the safety and efficacy of botanical treatments and there is also a chapter analysing the possible interactions of herbal remedies with prescription drugs. This is the most up-to-date text on the latest research findings from all over the world and will be an essential resource.Table of Contents1: Herbal Remedies with Geographical Historical Uses 2: Infectious Diseases Treatment and Immunomodulation 3: Treatment of Disorders 4: Cancer Prevention and Treatment 5: Cardiovascular Therapy 6: Diabetes 7: Therapy of Chronic Diseases 8: Botanicals and their extracts in Health Promotion 9: Interactions with other Medicines
£262.12
CABI Publishing Antimicrobial Drug Discovery: Emerging Strategies
Book SynopsisDrug resistance is increasing among a variety of human pathogenic microorganisms such as Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumaniii, Pseudomonas aeruginosa and Enterobacter spp. (currently dubbed the 'ESKAPE' pathogens), and has emerged as one of the most important clinical challenges of this century. Increased general awareness and fear of these pathogens means there is a growing demand for research to tackle the threat of multidrug resistance. Documenting the latest research in the field, this book discusses current and promising activities to discover new antimicrobials in five key areas: molecular genetics and systems microbiology; synthetic, computational chemistry and chemoinformatics; High Throughput Screening (HTS); non-vertebrate model hosts; and light- and nano-based technologies.Table of Contents1: Emerging Antimicrobial Drug-discovery Strategies: an Evolving Necessity 2: The Antibiotic Crisis 3: Structure, Genetic Regulation, Physiology and Function of the AcrAB-TolC Efflux Pump of Escherichia coli and Salmonella 4: Small-molecule Efflux Pump Inhibitors from Natural Products as a Potential Source of Antimicrobial Agents 5: Fungal Efflux-mediated Resistance: from Targets to Inhibitors 6: Vacuolar ATPase: a Model Proton Pump for Antifungal Drug Discovery 7: Drug Tolerance, Persister Cells and Drug Discovery 8: Inhibition of Quorum Sensing as a Novel Antimicrobial Strategy 9: Filamentous Temperature-sensitive Mutant Z (FtsZ) Protein as an Antibacterial Target 10: Lysostaphin: a Silver Bullet for Staph 11: Strategies to Identify Modified Ribosomally Synthesized Antimicrobials 12: Quantitative Structure-Activity Relationship-based Discovery of Antimicrobial Peptides Active Against Multidrug-resistant Bacteria 13: Acetyl-CoA Carboxylase as a Target for Antibacterial Development 14: Underexploited Targets in Lipopolysaccharide Biogenesis for the Design of Antibacterials 15: Predicting and Dissecting High-order Molecular Complexity by Information-driven Biomolecular Docking 16: Antifungals and Antifungal Drug Discovery 17: Pathosystematic Studies and the Rational Design of Antifungal Interventions 18: In Vivo High-throughput Antimicrobial Discovery Screens Utilizing Caenorhabditis elegans as an Alternative Host 19: Drosophila melanogaster as a Versatile Model for the Discovery of Drugs Effective against Human Microbe-induced Infection and Pathology 20: Antimicrobial Photosensitizers: Harnessing the Power of Light to Treat Infections 21: Nanoparticle Platforms for Antimicrobial Therapy 22: Antimicrobial Activity of Carbon Nanotubes
£131.26
Gordon & Breach Science Publishers SA Radiopharmacy and Radiopharmacology Yearbook
Book SynopsisFirst Published in 1985, this yearbook is an annual reference providing a concise source of information concerning recent developments in the radiopharmaceutical sciences.Table of ContentsIntroduction, Applications of Nuclear Medicine Techniques for the Development of Pharmaceutical Formulations, Sterility Testing of Radiopharmaceuticals, The Role of HPLC in the Development and Quality Control of Radiopharmaceuticals, Adverse Reactions and Drug Effects, Recent Developments in Technetium Chemistry as Applied to the Generation of New Radiopharmaceuticals, The Radiopharmacology of Iodinated Compounds: Present State and Perspectives, Aerosols for Inhalation Imaging, Polymers in Radiopharmacy, 99m Tc Labelled Radiopharmaceuticals for Thrombophleboscintigraphy: Aspects of Radiopharmacology, SELECTED ABSTRACTS
£999.99
Springer Nature Switzerland AG New Psychoactive Substances: Pharmacology,
Book SynopsisThis volume is designed to feature the pharmacology of new psychoactive substances, legislative aspects, information exchange including epidemiology, and clinical, forensic, and analytical toxicology in order to facilitate the understanding of this complex and rapidly developing phenomenon.Table of ContentsPreface.- Part I General Aspects.- 1. Self-Experiments with Psychoactive Substances: A Historical Perspective.- 2. Responding to New Psychoactive Substances in the European Union: Early Warning, Risk Assessment, and Control Measures.- 3. Emergence, Diversity, and Control of New Psychoactive Substances: A Global Perspective.- 4. Epidemiology of NPS Based Confirmed Overdose Cases: The STRIDA Project.- Part II Drug Classes.- 5. Neuropharmacology of Synthetic Cathinones.- 6. Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances.- 7. The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonists as New Psychoactive Substances: Origins.- 8. Molecular pharmacology of synthetic cannabinoids: Evolution.- 9. Synthetic Opioids.- 10. Designer Benzodiazepines: Another Class of New Psychoactive Substances.- 11. Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.- 12. 1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances.- 13. Phencyclidine-Based New Psychoactive Substances.- Part III Clinical, Forensic, and Analytical Toxicology.- 14. Bioanalytical Methods for New Psychoactive Substances.- 15. Wastewater Analysis for Community-Wide Drugs Use Assessment.- 16. Toxicokinetics of NPS: Update 2017.- 17. Patterns of Acute Toxicity Associated with New Psychoactive Substances.- 18. Fatal Poisonings Associated with New Psychoactive Substances.
£999.99
Springer Nature Switzerland AG Outbreak in the Village: A Family Doctor's
Book SynopsisOutbreak in the Village is a fascinating account of the personal and professional journey of Dr. Doug Jenkinson, physician and researcher. Over the course of four decades in practice, Jenkinson traces the reemergence of whooping cough in the developed world, using his practice in the idyllic English countryside as a clinical control group. Keeping meticulous notes and indulging an itch to investigate, he explores one of history's most enigmatic and pervasive diseases. Jenkinson relates the tale of his life's work amid winsome anecdotes, relevant history, and practical advice. Told in an amiable, engaging voice with an expert balance of levity and earnestness, this story will charm casual readers interested in medical history and memoir, as well as doctors and researchers who identify with the experiences and may benefit from the research and techniques employed. Readers will find themselves in the examination room beside Jenkinson as the investigation unfolds, learning about the nature of the illness and the sweeping detrimental effects of an anti-vaccination campaign. An intriguing memoir about a mysterious illness, a public health failure, and one doctor's quest for clarity, Outbreak in the Village is a tale of perseverance and objectivity sure to delight and inform.Table of Contents Introduction From Africa to England The children’s clinic at Keyworth Whooping cough vaccine 1977–9. The first outbreak of whooping cough Does the vaccine work? 1981. Whooping cough vaccine is very rarely harmful 1981–3. The second outbreak. How many cases are there really? 1985–7. The third outbreak. The search for subclinical infection 1987. Does the effectiveness of the vaccine wear off? 1988. Trying to raise the uptake of pertussis vaccine 1989–91. The fourth outbreak. The natural history of whooping cough 1990s. Whooping cough fades away but new diagnostic tests emerge 2000. Whoopingcough.net. Overcoming diagnostic paralysis The early noughties. The new tests aid the re-discovery of whooping cough Late noughties. ‘Resurgence’ of whooping cough in the USA and Australia puts the UK on alert 2012. Whooping cough diagnoses peak in the UK but remain unchanged in Keyworth What lies ahead? Epilogue About Bordetella bacteriaAge incidence changes in Keyworth whooping cough patients A critical look at recent pertussis statistics in England
£999.99
Springer Nature Switzerland AG Natural Products and Human Diseases:
Book SynopsisNatural products have a long history of use as folk medicines in several systems of traditional medicine. Extensive evidence from modern pharmacological studies has confirmed traditional applications, and unveiled the vast potential of naturally occurring compounds, particularly plant-derived phytochemicals, in the management of chronic human diseases. The past decade has witnessed a surge of findings from randomized controlled trials testifying the safety and efficacy of natural products as adjuncts or alternatives to standard-of-care medications for several illnesses. Biomolecular studies have unveiled hundreds of cellular and molecular targets for phytochemicals including key transcription factors, receptors, enzymes, hormones, neurotransmitters, cytokines, lipids, and non-coding RNAs.Extensive research on the preventative and therapeutic effects of natural products necessitates regular updating of the literature as to the developing potential roles of these compounds in different human diseases. This new book provides an overview of the current pharmacological and clinical features of natural products, and the role of phytopharmaceutical compounds in health and diseases. Chapters cover a wide scope, from cancers, to chronic and age-related disorders, and are written by leading international subject experts. Collectively, chapters will provide useful insights on the regulatory effects of phytochemicals and nutraceuticals on pathogenic molecular signatures associated with pathologies, disease biomarkers, and aging-related pathways.Table of Contents1. Effects of Curcuminoids on Systemic Inflammation and Quality of Life in Patients with Colorectal Cancer Undergoing Chemotherapy: a Randomized Controlled Trial2. Curcumin and Piperine Combination for the Treatment of Patients with Non-alcoholic Fatty Liver Disease: a Double-Blind Randomized Placebo-Controlled Trial3. Evaluation of the Effects of Nanomicellar Curcumin, Berberine and their Combination with 5-fluorouracilon Breast Cancer Cells4. The effect of herbal medicine and natural bioactive compounds on plasma adiponectin: a clinical review5. The effects of nutraceuticals and bioactive natural compounds on chronic periodontitis: a clinical review6. The multifaceted actions of curcumin in obesity7. Antiviral plants in view of Avicenna's Canon of Medicine and modern medicine against common cold8. Antifungal activity of curcuminoids and difluorinated curcumin against clinical isolates of Candida species9. Investigation of the effects of difluorinated curcumin on glycemic indices in streptozotocin- induced diabetic rats10. Evaluation of the Effect of Crocin on Doxorubicin-Induced Cardiotoxicity11. The role of chemokines in cardiovascular diseases and the therapeutic effect of curcumin on CXCL8 and CCL2 as pathological chemokines in atherosclerosis12. Health benefits of turmeric and curcumin against food contaminants13. The effects of curcumin plus piperine supplementation in patients with acute myocardial infarction: a randomized, double-blind and placebo-controlled trial14. Protective effects of curcumin on pulmonary arterial hypertension15. Protective effects of curcumin in the reproductive system: anti-toxic, semen cryopreservative and contraceptive actions16. Protective effects of curcumin phytosomes against high-fat diet-induced atherosclerosis17. The effects of curcumin on the side effects of anticancer drugs in chemotherapy: A randomized controlled trial18. Crocin Improves Diabetes-Induced Oxidative Stress via Down-Regulating the Nox-4 in Myocardium of Diabetic Rats19. Role of herbal medicines in the management of brain injury 20. The effects of ginsenosides on the Nrf2 signaling pathway21. The effect of green coffee bean extract on cardiovascular risk factors: A systematic review and meta-analysis22. Nanomicellar curcumin supplementation improves the clinical manifestations of HAM/TSP patients23. The effects of Ivy (Hedera helix) on respiratory problems and cough in humans: a review24. Safety and efficacy of oral supplementation of lentil (Lens culinaris Medic) in dry eye patients25. A review of Glycyrrhiza Glabra (Licorice) effects on Metabolic Syndrome26. Natural insulin sensitizers for the management of diabetes mellitus: a review of possible molecular mechanisms27. Evaluation of the anti-constipation effects of abdominal application of olive oil ointment in children 1-4 years old: A pilot placebo-controlled, double-blind, randomized clinical trial28. Therapeutic Potential of Pomegranate in Metabolic Disorders29. Resveratrol as a Probable Multi-headed Treatment approach for COVID-1930. A review on the phytochemistry, pharmacology, and therapeutic effects of Rheum ribes31. Anti-tumor and protective effects of melatonin: the potential roles of microRNAs32. Antioxidant effects of trehalose in an experimental model of type 2 diabetes33. Investigation of the effects of trehalose on glycemic indices in streptozotocin-induced diabetic rats34. Hepatoprotective effect of Trehalose: insight into its Mechanisms of Action35. Effect of vitamin D supplementation on the regulation of blood pressure in Iranian patients with essential hypertension: a clinical trial36. Boosting GLP-1 by natural products37. Naturally occurring SGLT2 inhibitors: a review 38. Renoprotective roles of curcumin
£999.99
Springer Nature Switzerland AG Cell Therapy: cGMP Facilities and Manufacturing
Book SynopsisThis new edition presents a fully-updated and expanded look at current Good Manufacturing Practice (cGMP) for cell therapy products. It provides a complete discussion of facility design and operation including details specific to cord blood banking, cell processing, vector production and qualification of a new facility. Several chapters cover facility infrastructure including cleaning and maintenance, vendor qualification, writing a Standard Operating Procedure, staff training, and process validation. The detailed and invaluable product information covers topics like labelling, release and administration, transportation and shipment, et al. Further chapters cover relevant topics like writing and maintaining investigational new drug applications, support opportunities in North America and the European Union, commercial cell processing and quality testing services, and financial considerations for academic GMP facilities. A chapter on future directions rounds out Cell Therapy: cGMP Facilities and Manufacturing making it essential reading for any cell therapy professional involved in the development, use, or management of this type of facility. Table of ContentsPart 1. Regulatory1. Regulation of Cell Therapy in the United States 2. Regulatory Landscape and Emerging Trends In Advanced Therapies Manufacturing: An EU Perspective 3. Australian Cellular Therapy Regulations 4. Landscape for Regenerative Medicine Manufacturing in Japan 5. GLP Regulations for Non-clinical studies 6. Ethical Considerations in Cell Therapy 7. Investigational New Drug Applications for Cell Therapy Products8. FDA Inspections 9. Commercialization of Investigational Cell Therapy Products Part 2 Quality Systems10. The Meaning of Quality 11. Development and Maintenance of a Quality Program12. Quality Control of Cellular Therapy Products and Viral Vectors 13. Quality Management Software – Q-Pulse 14. Selection of Contract Manufacturing and Testing Organizations Part 3 Facility Design15. Introduction: Facility Design 16. PACT CPFs - Examples Describing Different Cell Processing Facility Designs17. Design and Operation of a Multiuse GMP Facility at the City of Hope 18. Design and Operation of a Multiuse GMP Facility at the University of Miami 19. Design of a New Academic GMP Facility for Today and Beyond at the Dana-Farber Cancer Institute20. Design and Licensure of an American Cord Blood Bank 21. Indiana University Vector Production Facility (IUVPF) 22. Qualification and Commissioning of a New GMP Facility Part 4 Facility Infrastructure23. Environmental Monitoring 24. GMP Facility Cleaning and Maintenance 25. GMP Documentation 26. Process Validation 27. Equipment Qualification 28. Vendor Qualification and Supply Management 29. Staffing, Training and Competency Part 5 Product Management30. Product Accessioning, Tracing and Tracking 31. ISBT 128 in Labeling of Cellular Therapy Products 32. Product Processing, Manufacturing and Administration 33. Transport and Shipment of Cellular and Gene Therapy Products 34. Regenerative Medicine: The Newest Cellular Therapy35. Cellular Therapy Applications for COVID-19 Part 6 Professional Standards and Support Organizations36. Professional Standards for Cellular Therapy: The Foundation for the Accreditation of Cellular Therapy (FACT) 37. AABB Cell Therapy Standards38. USP Standards for Cell-based Therapies39. The Role of the National Institute of Standards Measurement Assurance for Cell Therapies40. National Science Foundation Engineering Research Center for Cell Manufacturing Technologies (CMaT) 41. Financial Considerations for Academic GMP Facilities 42. Governmental Support Opportunities for Cellular & Gene Therapies in the United States
£999.99
Springer Nature Switzerland AG Toxicology of Organophosphate Poisoning: New
Book SynopsisThis book addresses the consequences of high agricultural pesticide use over the last few decades in the form of organophosphate poisoning. The authors provide a background overview of organophosphate compounds, their environmental toxicity, non-target exposures and cases of human poisoning. The authors also compile and analyze data from the last two decades to demonstrate the toxicological aspects of organophosphates, and how they can pose a threat to human health. Readers will learn about the clinical manifestation of organophosphate exposure in humans, as well as the enzymatic pathways and mechanisms by which organophosphates are processed in the body and cause harm. The book concludes by providing techniques, practices and recommendations for how to manage organophosphate exposure and poisoning. It will be useful for clinicians and public health professionals, scientists, medical practitioners, researchers and environmental toxicologists. Table of ContentsChapter 1: Overview of organophosphate compounds.- Chapter 2: Toxicology of Organophosphate poisoning in humans.- Chapter 3: Enzymatic Targets of organophosphates.- Chapter 4: Computational insights of human acetylcholinesterase inhibition.- Chapter 5: New insights in Prophylactic approaches of human poisoning.- Chapter 6: Management of human Organophosphate poisoning.- Chapter 7: Summary.
£999.99
Springer Nature Switzerland AG Toxicology of Organophosphate Poisoning: New
Book SynopsisThis book addresses the consequences of high agricultural pesticide use over the last few decades in the form of organophosphate poisoning. The authors provide a background overview of organophosphate compounds, their environmental toxicity, non-target exposures and cases of human poisoning. The authors also compile and analyze data from the last two decades to demonstrate the toxicological aspects of organophosphates, and how they can pose a threat to human health. Readers will learn about the clinical manifestation of organophosphate exposure in humans, as well as the enzymatic pathways and mechanisms by which organophosphates are processed in the body and cause harm. The book concludes by providing techniques, practices and recommendations for how to manage organophosphate exposure and poisoning. It will be useful for clinicians and public health professionals, scientists, medical practitioners, researchers and environmental toxicologists. Table of ContentsChapter 1: Overview of organophosphate compounds.- Chapter 2: Toxicology of Organophosphate poisoning in humans.- Chapter 3: Enzymatic Targets of organophosphates.- Chapter 4: Computational insights of human acetylcholinesterase inhibition.- Chapter 5: New insights in Prophylactic approaches of human poisoning.- Chapter 6: Management of human Organophosphate poisoning.- Chapter 7: Summary.
£87.99
Springer Nature Switzerland AG Gene and Cellular Immunotherapy for Cancer
Book SynopsisClinical and preclinical exploration of gene and cellular immunotherapy have seen rapid growth and interest with the development and approval of five Chimeric Antigen Receptor T-cell (CAR-T) products for lymphoma and myeloma and one Bispecific T-Cell Engager (BiTE) for acute lymphoblastic leukemia (ALL). These advances have dramatically improved the management of patients with relapsed refractory lymphoma, myeloma and leukemia. Gene and Cellular Immunotherapy for Cancer offers readers a comprehensive review of current cellular and gene-based immunotherapies. Divided into eighteen cohesive chapters, this book provides an in-depth and detailed look into cellular-based immunotherapies including CAR-T, TCR-T, TIL, Viral CTLs, NK cells in addition to T/NK cell engagers, focusing on their historical perspectives, biology, development and manufacturing, toxicities and more. Edited by two leading experts on gene and cellular immunotherapy, the book will feature chapters written by a diverse collection of recognized and up-and-coming experts and researchers in the field, providing oncologists, immunologists, researchers and clinical and basic science trainees with a bench to bedside view of the latest developments in the field.Table of ContentsPart I: Overview1. The History of Cellular Therapies 2. Basics of Immunity Part II: CAR-T3. Biology of CAR-T 4. Cell Types Used for CAR-T Generation5. Combination Therapeutics with CAR-T Cell Therapy 6. Safety Switches Used for Cellular Therapies7. Off the Shelf CAR-T8. Manufacturing of CAR-T Cells: the Assembly Line9. Navigating Regulations in Gene and Cell Immunotherapy10. Bringing CAR-T to the Clinic11. CAR-T Cell Complications 12. Mechanisms of Resistance and Relapse after CAR-T Cell Therapy Part III: TIL13. Tumor Infiltrating Lymphocytes (TIL): From Bench to Bedside Part IV: TCR14. T-cell Receptor (TCR) Engineered Cells and Their Transition to Clinic Part V: Viral CTLs15. Viral Cytotoxic T Lymphocytes (CTLs): from Bench to BedsidePart VI: NK Cell16. Biology of NK Cells and NK Cells in Clinic Part VII: T/NK cell engagers17. Biology and Clinical Evaluation of T/NK Cell Engagers Part VIII: Logistics 18. Roadmap for Starting an Outpatient Cellular Therapy Program
£999.99
Springer Nature Switzerland AG Formulating Poorly Water Soluble Drugs
Book SynopsisThe objective of this third edition is to consolidate within a single text the most current knowledge, practical methods, and regulatory considerations pertaining to formulations development with poorly water-soluble molecules. A pharmaceutical scientist’s approach toward solubility enhancement of a poorly water-soluble molecule typically includes detailed characterization of the compound’s physiochemical properties, solid-state modifications, advanced formulation design, non-conventional process technologies, advanced analytical characterization, and specialized product performance analysis techniques. The scientist must also be aware of the unique regulatory considerations pertaining to the non-conventional approaches often utilized for poorly water-soluble drugs. One faced with the challenge of developing a drug product from a poorly soluble compound must possess at a minimum a working knowledge of each of the above mentioned facets and detailed knowledge of most. In light of the magnitude of the growing solubility problem to drug development, this is a significant burden especially when considering that knowledge in most of these areas is relatively new and continues to develop.Table of ContentsContents 1. Route-Specific Challenges in the Delivery of Poorly Water-Soluble Drugs ……………….. Zachary Warnken, Hugh D.C. Smyth, and Robert O. Williams III 2. Optimizing the Formulation of Poorly Water-Soluble Drugs………………………….. Xiangyu Ma, Daniel Ellenberger, Kevin P. O’Donnell, and Robert O. Williams III 3. Solid-State Techniques for Improving Solubility ……………………………………….. Miguel O. Jara, Justin R. Hughey, Siyuan Huang, and Robert O. Williams III 4. Mechanical Particle-Size Reduction Techniques…………………………..……….…… Javier O. Morales, Alan B. Watts, and Jason T. McConville 5. Co-solvent and Complexation Systems …………………………………………….... Junhuang Jiang and Robert O. Williams III 6. Injectable Formulations of Poorly Water-Soluble Drugs ………………………….…... Hannah L. O’Mary and Zhengrong Cui, 7. Lipid-Based Formulations…………………………………………………................... Daniel A. Davis Jr., Han-Hsuan Peng, and Robert O. Williams III 8. Structured Development Approach for Amorphous Systems ……………………….... Susanne Page, Reto Maurer, Nicole Wyttenbach, and Felix Ditzinger 9. Melt Extrusion………………………………………………………………………. Stephen A. Thompson, Daniel A. Davis Jr., James C. DiNunzio, Charlie Martin, Robert O. Williams III, and Feng Zhang 10. Spray-Drying Technology…………..………..………..………..……………………….. Dave A. Miller, Daniel Ellenberger, Tiago Porfirio, and Marco Gil 11. Pharmaceutical Cryogenic Technologies ………………………………………….... Sawittree Sahakijpijarn, Chaeho Moon, and Robert O. Williams III 12. Precipitation Technologies for Nanoparticle Production ……………………………. Tuangrat Praphawatvet and Robert O. Williams III 13. Emerging Technologies to Increase the Bioavailability of Poorly Water-Soluble Drugs … Daniel A. Davis Jr., Rishi Thakkar, Mohammed Maniruzzaman, Dave A. Miller, Robert O. Williams III 14. Scientific and Regulatory Considerations for Development and Commercialization of Poorly Water-Soluble Drugs…………………………………………………………………. .Zedong Dong and Hasmukh Patel
£999.99
Springer Nature Switzerland AG The Kappa Opioid Receptor
Book SynopsisThis book covers the latest knowledge in structure, signaling, and biochemical pharmacology of KOR as well as preclinical research and clinical applications (including clinical phase studies and approved for human use) of KOR compounds. It is divided up into the three parts: Molecular aspects of KOR, Preclinical research on pharmacology of KOR agonists and antagonists in animals and KOR agonists and antagonists in clinical use and in past and present clinical trials.The chapters "Biosensors monitor ligand-selective effects at kappa opioid receptors" and "The role of dynorphin and the kappa opioid receptor in schizophrenia and major depressive disorder: a translational approach" of this book are available open access under a Creative Commons Attribution 4.0 International License via link.springer.com.Table of Contents
£107.99
Springer International Publishing AG Deuterium Oxide and Deuteration in Biosciences
Book SynopsisThis new book provides comprehensive coverage of the subjects of deuterium oxide and deuteration in biosciences, with an emphasis on the biochemical, biomedical, and pharmacological aspects. Deuterium oxide and deuteration effects also offer various implications for health-related issues, including diseases, vaccines and drugs. Organized in six sections, the chapter topics include the role of regular and heavy water in biosciences, and their implications to biomolecules, biochemical processes, health-related research, and pharmacology. Due to the broad scope, the book may be used as a supplemental text for upper-level undergraduate and graduate courses in the related fields of biochemistry, biology, biomedical sciences, biophysics, and pharmacology. Researchers and pharmaceutical industry professionals will also find the content useful in order to gain knowledge and better understand the implications of deuterium oxide and deuteration research.Table of ContentsSection I. Roles of regular and heavy water in biosciences Overview: background and applications Characteristics of deuterium oxide versus hydrogen oxide Section II. Molecular interactions of deuterium versus hydrogen oxide Deuterium bonding versus hydrogen bonding Hydrophobic interaction in D2O versus H2O Section III. Implications of deuterium oxide and deuteration in biological Systems Deuterium oxide and deuteration effects on biomolecules Effects of D2O and deuteration on biomembranes Section IV. Applications of D2O and deuteration to biochemical reactions Biochemical effects of deuterium oxide and deuteration Physical methods for investigating D2O and deuteration effects Section V. Exploration of deuterium oxide and deuteration in health-related research Living cells grown in deuterium oxide and deuteration Deuterium oxide and deuteration effects on health issues Section VI. Applications of deuterium oxide and deuteration to pharmacology Deuterium oxide effects on thermostability of vaccines Deuterium oxide and deuteration effects on pharmacology
£104.49
Springer Sustainable Global Health Systems and
Book SynopsisHealth Care Industry.-? Reimbursement and Pricing?.- Current Stage of Pharmaceutical Development?.- Desired Future State of Pharmaceutical Development?.- Case Studies I?.- Case Studies II?.- Case Studies III.
£999.99
Kohlhammer Klinische Pharmakologie in Der
Book Synopsis
£30.60
Kohlhammer W. Psychopharmaka Und Drogen
Book Synopsis
£21.25
Springer International Publishing AG Chromatographic Fingerprint Analysis of Herbal
Book SynopsisVolume III of this manual provides an overview of the analytical investigation of 23 additional Chinese Herbal Drugs, which are most commonly used in Traditional Chinese Medicine. Together with Volumes I and II this current volume represents the most comprehensive overview to analytical studies of those herbal drugs. The quality proof of the investigation meets the standard of the European Drug Regulatory Authority. The authors refer to the bioactive constituents, pharmacological and biological activities of all single herbal drugs, as well as their therapeutic applications. Analytical methods applied are described in detail.Trade Review“The book is a reference work for the analysis/identification of herbal drugs since it gives the extraction conditions and the specific chromatographic procedures to be used. … I would recommend this book … to all those interested in the uses and properties of herbal medicines.” (Edward R. Adlard, Chromatographia, Vol. 78, 2015)Table of ContentsCrataegi, Fructus et Folium.- Cyperi, Rhizoma.- Lycopodii, Herba.- Saposhnikoviae, Radix.- Glycyrrhizae, Radix et Rhizoma.- Gynostemmatis, Herba.- Sarcandrae, Herba.- Ligustri lucidi, Fructus.- Moutan, Cortex.- Peucedani, Radix.- Achyranthis, Radix.- Bambusae, Caulis.- Lysimachiae christinae, Herba.- Desmodii styracifolii, Herba.- Luffae, Fructus.- Oldenlandiae, Herba.- Siraitiae (Momordicae).- Fructus Morindae officinalis, Radix.- Apocyni veneti, Folium.- Eriocauli, Flos.- Spatholobi, Caulis.- Aucklandiae, Radix.- Platycodonis, Radix.
£134.99
Springer International Publishing AG Toxicological Risk Assessment for Beginners
Book SynopsisThis book serves as a comprehensive introductory guide to the practical aspects of risk assessment. Chapters include clearly defined objectives and summaries. The book includes: hazard identification, dose-response, exposure assessment, risk characterization, chemical mixtures, epidemiology, emerging issues and global perspectives with accessible language. The book concludes with a set of hypothetical case studies.Toxicological Risk Assessment for Beginners aims not to create an expert, but rather to provide readers with their first understanding of the risk assessment topic. This book was designed with the student in mind. We simplify a complex process for beginners and balance theory with practical aspects, but remain fluid enough to increase difficulty with case studies. By incorporating an action based, step by step approach to learning the risk assessment process, this book provides its readers with an elementary understanding of how the risk assessment process is initiated, developed and finished, making it a valuable guide for graduate students, post-doctoral fellows and early career scientists in industry.Table of ContentsIntroduction.- Hazard Identification.- Dose-Response.- Exposure Assessment.- Risk Characterization for Human Health Risk Assessments.- Risk Assessment Strategies and Techniques for Combined Exposures.- Use of Epidemiology in Risk Assessment.- Emerging Issues in Risk Assessment.- Risk Assessment in the European Union (EU).- Brief Survey of Global Approaches for Risk Assessment.- Skills Development and Resources for Risk Assessment.- Case Studies Chapter.
£999.99
Springer International Publishing AG Critical Care Toxicology: Diagnosis and
Book SynopsisBuilding on the previous edition with contributions from internationally renowned experts this book provides a fully comprehensive resource for managing the post emergency/treatment stage of acute poisoning. Chapters incorporate evidence-based paradigms with up-to-date citations from the original medical literature. Topic areas covered include: diagnosis and management of the critically poisoned patient, including pediatric patients and poisoning in pregnancy; toxic syndromes including hepatotoxic and pulmonary syndromes as well as poisonings from medications, drugs of abuse, chemical and biological agents. This book is an essential resource for Clinical Toxicologists, Intensivists and Emergency Medicine specialists in training and in practice.Trade Review“This is a valuable addition to the archives of clinical toxicology and will undoubtedly become the standard for the profession. … I highly recommend this book as a necessary addition to the professional library of every medical student and resident with an interest in clinical toxicology as well as practitioners at all levels (nurses, fellows, residents, and attending level physicians) of critical care, intensive care, emergency medicine, and clinical and medical toxicology.” (Michael I. Greenberg, Clinical Toxicology, Vol. 56 (3), December, 2017)Table of Contents4-Dimethylaminophenol.- Acetaminophen (Paracetamol).- Beta Receptor Antagonists.- Cardiac Conduction and Rate Disturbances.- Digitalis Glycosides.- Extracorporeal Membrane Oxygenation and Cardiopulmonary Bypass in the Poisoned Patient.- Fumigants.- Gyromitra Mushrooms.- Hydrocarbons and Halogenated Hydrocarbons.- Irritant and Toxic Respiratory Injuries.- Lipid Resuscitation Therapy.- Marine Vertebrates, Cnidarians and Mollusks.- Nerve Agents.- Organophosphorus and Carbamate Insecticides.- Phosphine and Metal Phosphide.- Rifampin, Dapsone, and Vancomycin.- Salicylates.- Thallium.- Unithiol (DMPS).- Valproic Acid.- Widow and Related Lactrodectus Spiders.
£999.99
Springer International Publishing AG Toxicological Risk Assessment for Beginners
Book SynopsisThis book serves as a comprehensive introductory guide to the practical aspects of risk assessment. Chapters include clearly defined objectives and summaries. The book includes: hazard identification, dose-response, exposure assessment, risk characterization, chemical mixtures, epidemiology, emerging issues and global perspectives with accessible language. The book concludes with a set of hypothetical case studies.Toxicological Risk Assessment for Beginners aims not to create an expert, but rather to provide readers with their first understanding of the risk assessment topic. This book was designed with the student in mind. We simplify a complex process for beginners and balance theory with practical aspects, but remain fluid enough to increase difficulty with case studies. By incorporating an action based, step by step approach to learning the risk assessment process, this book provides its readers with an elementary understanding of how the risk assessment process is initiated, developed and finished, making it a valuable guide for graduate students, post-doctoral fellows and early career scientists in industry.Table of ContentsIntroduction.- Hazard Identification.- Dose-Response.- Exposure Assessment.- Risk Characterization for Human Health Risk Assessments.- Risk Assessment Strategies and Techniques for Combined Exposures.- Use of Epidemiology in Risk Assessment.- Emerging Issues in Risk Assessment.- Risk Assessment in the European Union (EU).- Brief Survey of Global Approaches for Risk Assessment.- Skills Development and Resources for Risk Assessment.- Case Studies Chapter.
£69.99
Springer International Publishing AG Orexin and Sleep: Molecular, Functional and
Book SynopsisThis volume is intended for neuropharmacologists, psychopharmacologists, pharmacologists, pharmacists, sleep researchers, translational neuroscience researchers, and other basic researchers and clinical scientists interested in an interdisciplinary approach to sleep medicine. The level of the book is aiming at CNS researchers, drug development scientists, basic and clinical sleep researchers, as well as senior medical students and fellows in psychiatry and neurology. Orexin and Sleep provides a unique resource, giving a comprehensive and highly readable summary of the basic concepts in orexin biology and pharmacology along with clinical applications in sleep medicine in general, and narcolepsy in particular.Trade Review“This is an up-to-date look at these hypothalamic neuropeptides and how we have come to understand their wide range of neuroregulatory roles. … This is highly technical book that reviews in detail the research that has led to the discovery and understanding of the orexin neuropeptides and their role in a wide range of neuromodulatory systems. … provide some insights into how manipulation of this system may result in therapeutic interventions for a number of neurological and psychiatric conditions.” (Michael Easton, Doody’s Book Reviews, February, 2016)Table of ContentsHistory of Orexin Research.- The Hypocretin Story.- Input and output systems of orexin neurons.- Physiological roles of orexin receptors on sleep/wakefulness regulation.- Orexin receptor functions in the ascending arousal system (Folder name - Leonard).- Elucidation of neuronal circuitry involved in the regulation of sleep/wakefulness using optogenetics (Folder name - Yamanaka).- Modulation of thalamocortical pathways by orexins.- Orexins, Alcohol and Sleep Homeostasis.- Orexin induced modulation of REM sleep and its loss associated patho-physiological changes are mediated through locus coeruleus.- Role of orexin on sleep: interactions with other neurotransmitter systems.
£999.99
Springer International Publishing AG Blue Biotechnology: From Gene to Bioactive
Book SynopsisThis book describes the discovery of molecules from unexploited extreme marine environments, and presents new approaches in marine genomics. It combines the current state of knowledge in marine genomics and advanced natural products’ chemistry to pursue the sustainable production of novel secondary metabolites (lead compounds), as well as pharmacologically active peptides/proteins, with antimicrobial, neuroprotective, anti-osteoporotic, anti-protozoan/anti-plasmodial, anti-ageing and immune-modulating effects. Further, it employs molecular-biology-based approaches and advanced chemical techniques to obtain and to select candidate compounds for pre-clinical and clinical studies.Table of Contents35 Years of Marine Natural Product Research in Sweden: Cool Molecules and Models from Cold Waters.- Major Antimicrobial Representatives from Marine Sponges and/or Their Associated Bacteria.- Discovery and Development of Novel Drugs.- Computer Aided Drug Discovery from Marine Compounds: Identification of the Three-dimensional Structural Features Responsible for Antimalarial Activity.- BlueGenics: Bioactive Natural Products of Medicinal Relevance and Approaches to Their Diversification.- New Target Sites for Treatment of Osteoporosis .- Biocalcite and Carbonic Acid Activators.- Electrospinning of Bioactive Wound Healing Nets.- Entotheonella Bacteria as Source of Sponge-derived Natural Products: Opportunities for Biotechnological Production.
£112.49
Urban & Fischer/Elsevier Allgemeine und spezielle Pharmakologie und
Book Synopsis
£84.15
Urban & Fischer/Elsevier Basics Pharmakologie
Book Synopsis
£24.30
Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Biologie der Antibiotica
Book SynopsisTable of ContentsI. Einleitung.- II. Antibioticabildung und Systematik der Mikroorganismen.- Literatur.- III. Der Nachweis einer antibiotischen Wirkung.- A. Faktoren, die eine antibiotische Wirkung beeinflussen.- 1. Der Einfluß der Wachstumsphase.- 2. Der Einfluß des Nährbodens.- 3. Der Einfluß der Antibioticadosierung.- 4. Der Einfluß der Populationsdichte.- 5. Der Einfluß der Wachstumsgeschwindigkeit.- 6. Die Bedeutung der Resistenzrate.- B. Ausgewählte Standardmethoden.- 1. Der Verdünnungsreihentest.- 2. Der Plattendiffusionstest.- 3. Der Agar-Verdünnungsstrichtest (AVS-Test).- C. Spezielle Testverfahren.- 1. Der Agar-Querstrichtest.- 2. Der Kreuztest.- 3. Der Streifengradient-Test.- 4. Tests im Zusammenhang mit der Erfassung einer allfälligen Antitumor-Wirkung.- Literatur.- IV. Antibiotica-Biogenese.- A. Niedere Fettsäuren als biogenetische Einheiten von Antibiotica.- 1. Das Alternariol.- 2. Das Atrovenetin.- 3. Das Griseofulvin.- 4. Das Curvularin.- 5. Die Makrolid-Antibiotica.- 6. Die Tetracycline.- B. Aminosäuren als Bausteine von Antibiotica.- 1. Cycloserin und O-Carbamyl-D-Serin.- 2. Penicillin.- 3. Die Cephalosporine N und C.- 4. Antibiotica der Thiolutin-Holomycin-Gruppe.- 5. Gliotoxin.- 6. Novobiocin (Cathomycin, Streptonivicin, Albamycin, Cardelmycin).- C. Zucker als biogenetische Einheiten von Antibiotica.- D. Purinstoffwechsel und Antibiotica-Biogenese.- E. Pyrimidine als.Bausteine von Antibiotica.- Literatur.- V. Die Wirkungsweise von Antibiotica.- A. Möglichkeiten, Auskunft über die Wirkungsweise eines Antibioticums zu erhalten.- B. Antibiotica und Zellwandsynthese.- C. Antibiotica und die osmotische Barriere der Zellen.- D. Antibiotica, die in den Nucleinsäure- und Proteinstoffwechsel eingreifen.- 1. Molekularbiologische Grundlagen der Proteinsynthese.- 2. Antibiotica, die in diesen Prozeß eingreifen.- E. Antibiotica und Purinsynthese.- F. Antibiotica und Eisenstoffwechsel.- Literatur.- VI. Antibiotica-Resistenz.- A. Bedeutung der Antibiotica-Resistenz.- B. Charakterisierung der Resistenz und Entscheidung resistant-empfindlich.- C. Die Entstehung induzierter Resistenz.- 1. Die Einschritt-Resistenz.- 2. Die Vielschritt-Resistenz.- D. Die physiologischen Grundlagen der Resistenz.- 1. Resistenz durch Abbau des Antibioticums.- 2. Resistenz ohne Abbau des Antibioticums.- 3. Das Antibioticum wird benötigt.- E. Die gekreuzte Resistenz.- F. Versuche zur Lösung des Resistenzproblems in der Medizin.- 1. Verhinderung der Resistenzentstehung während der Therapie.- 2. Verhinderung der Entstehung und der Ausbreitung resistenter Keime.- 3. Die Überwindung einer aufgetretenen Resistenz.- Literatur.- VII. Die Suche nach neuen Antibiotica.- A. Gründe für die Suche nach neuen Antibiotica.- B. Die Möglichkeiten der Suche nach neuen Antibiotica.- 1. Die gezielte Synthese.- 2. Die Verbesserung bereits bekannter Wirkstoffe.- 3. Die empirische Suche nach neuen Antibiotica.- Literatur.
£999.99
Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Therapie der koronaren Herzerkrankung: Aktuelle
Book SynopsisDieser Band gibt einen Überblick über aktuelle Aspekte der koronaren Herzkrankheit, von der heute nahezu jeder 2. Bundesbürger betroffen ist. Namhafte Experten diskutieren die Bewertung von Risikofaktoren und Perspektiven der primären und sekundären Prävention, die Rolle von Endothel und Thrombozyten und die sich daraus ergebenden therapeutischen Implikationen bei stabiler und instabiler Angina pectoris. Das Problem der asymptomatischen Myokardischämie und ihrer Behandlung, die Möglichkeiten und Grenzen der Pharmakotherapie, die gegenwärtigen Konzepte zur Behandlung des akuten Myokardinfarktes sowie der Stellenwert der PTCA und neuerer Entwicklungen wie die Laser-Angioplastie werden dargestellt. Hervorzuheben sind die angioskopischen Aufnahmen, die den Blick in das Innere von arteriosklerotisch veränderten Herzkranzgefäßen erlauben. Damit gibt dieses Buch wertvolle Informationen für die ärztliche Tätigkeit bei der Therapie der koronaren Herzkrankheit.Table of ContentsIntervention in Risk Factors of Ischemic Heart Disease.- Vasodilatation durch Nitrate und EDRF.- Angina pectoris — Warum wird eine stabile Form instabil?.- New Results in Coronary Angioscopy.- Silent Myocardial Ischemia.- Pharmakotherapie der symptomatischen und asymptomatischen Myokardischämie.- Chronopharmakologie antiischämisch wirksamer Arzneimittel.- Therapie des akuten Myokardinfarktes mit Thrombolyse und PTCA.- Perkutane transluminale Koronarangioplasie: Neuere Entwicklungen - Komplikationen und Empfehlungen.- Recent Advances in Excimer Laser Angioplasty.- Laserangioplastie und andere in der Entwicklung befindliche Rekanalisationstechniken.
£999.99